FDA.reportPublic FDA data

Jatenzo 158 MG Oral Capsule

RxCUI
2201640
RxNorm name
Jatenzo 158 MG Oral Capsule
Display name
Jatenzo 158 MG Oral Capsule
Full name
Jatenzo 158 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ed7b5d41-7475-4c10-99b9-b62b3434ae60JATENZO 158 MG Oral Capsule [PSN] · testosterone undecanoate 158 MG Oral Capsule [Jatenzo] [SBD] · Jatenzo 158 MG Oral Capsule [SY]312These highlights do not include all the information needed to use JATENZO ® safely and effectively. See full prescribing information for JATENZO. JATENZO (testosterone undecanoate) capsules, for oral use CIII Initial U.S. Approval: 195320250915